Brief Behavioural Economic Intervention for Smoking Cessation
ConditionTobacco Smoking
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Hong Kong
About this trial
The goal of this clinical trial is to test the effectiveness of brief behavioural economic intervention in promoting smoking cessation among smokers in the community.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Hong Kong residents aged 18 years or above
Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
Exhaled carbon monoxide level ≥4 parts per million or a positive salivary cotinine test
Able to communicate in and read Chinese
Disqualifiers
Participating in another smoking cessation programme or using any smoking cessation drug or nicotine replacement therapy
Trial design
Design model
Parallel
Treatments tested in this trial
Brief cessation advice
BehavioralParticipants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model: A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Opt-out active referral
BehavioralParticipants will be automatically referred to a smoking cessation service upon joining the trial, unless they choose to opt out. Contacts of participants will be delivered to a service provider of their choice or based on their living district and preferred treatment modality
Behavioral economic mobile messaging
BehavioralParticipants will receive behavioural economics-informed messages via mobile instant messaging for 3 months
Opt-in active referral
BehavioralParticipants will be offered a referral to a smoking cessation service. Contacts of participants who opt-in will be delivered to a service provider of their choice
Treatment groups
1,017 Participants
are divided into 3 treatment groupsGroup A: Opt-out+ groupExperimental treatment 3 interventions
Group B: Opt-out groupExperimental treatment 2 interventions
Group C: Opt-in groupActive comparator 2 interventions
Trial outcomes
Primary outcomes
1
Biochemically validated tobacco abstinence
Verified by an exhaled carbon monoxide level of \<4 parts per million and a negative salivary cotinine test
Time frame
6 months after randomisationSecondary outcomes
1
Biochemically validated tobacco abstinence
Verified by an exhaled carbon monoxide level of \<4 parts per million and a negative salivary cotinine test
Time frame
3 months after randomisation2
Self-reported 7-day point-prevalence tobacco abstinence
Tobacco abstinence in the past 7 days
Time frame
3 months after randomisation3
Self-reported 7-day point-prevalence tobacco abstinence
Tobacco abstinence in the past 7 days
Time frame
6 months after randomisation4
Self-reported 24-hour quit attempt
Tobacco abstinence for at least 24 hours
Time frame
3 months after randomisationOther outcomes
1
Self-reported reduction of tobacco consumption
Smoking reduction by at least half of the baseline daily number of cigarettes
Time frame
3 months after randomisation2
Self-reported reduction of tobacco consumption
Smoking reduction by at least half of the baseline daily number of cigarettes
Time frame
6 months after randomisationSponsors and contacts
Click on the lead sponsor to view all of their trials.
The University of Hong Kong
Lead sponsor
Hong Kong Council on Smoking and Health
Collaborator
Source ClinicalTrials.gov